ondansetron has been researched along with Mood Disorders in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ondansetron has been shown to be an effective treatment for early-onset alcoholism." | 5.10 | Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals. ( Ait-Daoud, N; Johnson, BA; Ma, JZ; Wang, Y, 2003) |
| " Emetic episodes, doses of rescue medications to treat breakthrough nausea or vomiting, and occurrence of adverse events were recorded." | 1.34 | Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy. ( Cartwright, J; Frangoul, H; Ho, RH; Jones, E; Koyama, T; Kuttesch, J; Shankar, S; Whitlock, JA, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, BA | 1 |
| Ait-Daoud, N | 1 |
| Ma, JZ | 1 |
| Wang, Y | 1 |
| Jones, E | 1 |
| Koyama, T | 1 |
| Ho, RH | 1 |
| Kuttesch, J | 1 |
| Shankar, S | 1 |
| Whitlock, JA | 1 |
| Cartwright, J | 1 |
| Frangoul, H | 1 |
1 trial available for ondansetron and Mood Disorders
| Article | Year |
|---|---|
Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals.
Topics: Adult; Aged; Alcoholism; Confidence Intervals; Double-Blind Method; Female; Humans; Male; Middle Age | 2003 |
1 other study available for ondansetron and Mood Disorders
| Article | Year |
|---|---|
Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Confusion; Dexamethasone; D | 2007 |